Semaglutide — GLP-1 therapy, prescribed and monitored by licensed providers

Semaglutide

GLP-1 therapy, prescribed and monitored by licensed providers
Licensed US provider reviewed

A GLP-1 therapy prescribed for weight management. Semaglutide mimics a natural hunger hormone to reduce appetite — guided by licensed providers from intake to ongoing care. Individual results vary.

Licensed provider oversight US pharmacy delivery Dose escalation available

Reviewed by a licensed US provider.

Your assessment is reviewed by a licensed clinician. Approved treatments ship from a licensed US compounding pharmacy in plain, discreet packaging.

Start Assessment